Active, not recruitingPhase 3NCT06143891
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
Studying Chronic graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sanofi
- Intervention
- Belumosudil(drug)
- Enrollment
- 260 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2024 – 2028
Study locations (30)
- University of Arkansas for Medical Sciences-Site Number : 8400019, Little Rock, Arkansas, United States
- City of Hope National Medical Center- Site Number : 8400001, Duarte, California, United States
- University of California San Francisco - Parnassus Heights- Site Number : 8400035, San Francisco, California, United States
- AdventHealth Orlando- Site Number : 8400023, Orlando, Florida, United States
- The Hope Clinic of Emory University- Site Number : 8400020, Decatur, Georgia, United States
- Northwestern University- Site Number : 8400017, Chicago, Illinois, United States
- Indiana University Health University Hospital- Site Number : 8400006, Indianapolis, Indiana, United States
- University of Kentucky Chandler Medical Center- Site Number : 8400024, Lexington, Kentucky, United States
- Johns Hopkins Hospital- Site Number : 8400033, Baltimore, Maryland, United States
- Dana Farber Cancer Institute Site Number : 8400005, Boston, Massachusetts, United States
- Karmanos Cancer Institute - Detroit- Site Number : 8400013, Detroit, Michigan, United States
- UNC Children's Hospital- Site Number : 8400025, Chapel Hill, North Carolina, United States
- Atrium Health Wake Forest Baptist Medical Center - Winston-Salem - Medical Center Boulevard- Site Number : 8400007, Winston-Salem, North Carolina, United States
- Oncology Hematology Care - Kenwood- Site Number : 8400030, Cincinnati, Ohio, United States
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute- Site Number : 8400026, Columbus, Ohio, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06143891 on ClinicalTrials.govOther trials for Chronic graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07394608Paired Non-invasive VNS in Adolescent Cerebral Palsy RehabilitationIcahn School of Medicine at Mount Sinai
- RECRUITINGPHASE2NCT07124078A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)Incyte Corporation
- RECRUITINGEARLY PHASE1NCT07355868Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyRegend Therapeutics
- RECRUITINGNANCT06857929"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"IMDEA Food
- RECRUITINGPHASE1NCT07389044A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- RECRUITINGNCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHDM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT07138196A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host DiseaseQurient Co., Ltd.
- ACTIVE NOT RECRUITINGNCT07321080Central Sensitisation in Nociceptive and Neuropathic PainIRCCS Centro Neurolesi Bonino Pulejo